Stanozolum 50 - Magnum Laboratories

While many anabolic steroids faced limited therapeutic success, Stanozolol was widely used after its release in 1962. Known as Winstrol, it was developed by Winthrop Laboratories and prescribed for treating cachexia, stunted growth, and bone diseases. Its chemical design—a pyrazole-substituted DHT derivative—allowed oral activity and high anabolic efficiency. It was later used in animals to support recovery and conditioning. Though eventually removed from U.S. markets, it is still produced in countries like Spain, where its injectable form retains legal medical use.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Stanozolum 50 by Magnum Laboratories, consult with your doctor or healthcare professional.